Zoledronic acid and angiogenesis [2]

Clinical Cancer Research

Volumn 13, Issue 22, 2007, Pages 6850-

  Santini, Daniele ^a   Vincenzi, Bruno ^a   Tonini, Giuseppe ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; VASCULOTROPIN; ZOLEDRONIC ACID;

ANGIOGENESIS; BLOOD LEVEL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CONNECTIVE TISSUE CELL; DRUG ACCUMULATION; DRUG EFFECT; DRUG INTERMITTENT THERAPY; ENDOTHELIAL TUMOR STROMA; GROWTH RETARDATION; LETTER; PRIORITY JOURNAL; STEM CELL; STEM CELL MOBILIZATION; TUMOR CELL; TUMOR GROWTH;

EID: 36749051225     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4408     Document Type: Letter

References (8)

1. Santini D, Vincenzi B, Galluzzo S, et al. Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients. Clin Cancer Res 2007;13:4482-6.
2. Ferretti G, Fabi A, Carlini P, Papaldo P, Felici A, Cognetti F. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. Bone 2007;41:155-6.
3. Daubine F, Le Gall C, Gasser J, Green J, Clezardin P. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. J Natl Cancer Inst 2007;99:322-30.
4. Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302:1055-61.
5. + cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8.
6. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone marrow derived endothelial and haematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201.
7. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-9.
8. Bertolini F, Paul S, Mancuso P, et al. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 2003;63:4342-6.